Browse By: Country ι Category ι Tag

Avastin Market Research Reports

Avastin-Drug Insights, 2017
Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug. Scope • A review of the Avastin based on information derived from company and industry-specific sources • Coverage of the Marketed data of the Avastin on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification • Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Avastin with location details • Patent Expiry Timeline and Exclusi
Published Date: Jan 2017
Published By: DelveInsight

Price: $1000
Global Avastin Sales Market Report 2016
Sales, means the sales volume of Avastin Revenue, means the sales value of Avastin This report studies sales (consumption) of Avastin in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Sanofi SA (France) GlaxoSmithKline Plc (UK) Genzyme Corp. (USA) Eli Lilly and Company (US) Pfizer Inc. (USA) Abbott Laboratories (USA) Merck & Co., Inc. (US) Wyeth (US) Eisai Inc. (USA) Warner Chilcott plc (Ireland) Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Avastin in these regions, from 2011 to 2021 (forecast),
Published Date: Dec 2016
Published By: QYResearch

Price: $4000
United States Avastin Market Report 2016
Sales, means the sales volume of Avastin Revenue, means the sales value of Avastin This report studies sales (consumption) of Avastin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Sanofi SA (France) GlaxoSmithKline Plc (UK) Genzyme Corp. (USA) Eli Lilly and Company (US) Pfizer Inc. (USA) Abbott Laboratories (USA) Merck & Co., Inc. (US) Wyeth (US) Eisai Inc. (USA) Warner Chilcott plc (Ireland) Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Avastin in each application, can be divided into Application 1 Application 2 Application 3
Published Date: Dec 2016
Published By: QYResearch

Price: $3800
Europe Avastin Market Report 2016
Sales, means the sales volume of Avastin Revenue, means the sales value of Avastin This report studies sales (consumption) of Avastin in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Sanofi SA (France) GlaxoSmithKline Plc (UK) Genzyme Corp. (USA) Eli Lilly and Company (US) Pfizer Inc. (USA) Abbott Laboratories (USA) Merck & Co., Inc. (US) Wyeth (US) Eisai Inc. (USA) Warner Chilcott plc (Ireland) Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Avastin in these countries, from 2011
Published Date: Nov 2016
Published By: QYResearch

Price: $3900
Global Avastin Market Research Report 2016
Production, means the output of Avastin Revenue, means the sales value of Avastin This report studies Avastin in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering Sanofi SA (France) GlaxoSmithKline Plc (UK) Genzyme Corp. (USA) Eli Lilly and Company (US) Pfizer Inc. (USA) Abbott Laboratories (USA) Merck & Co., Inc. (US) Wyeth (US) Eisai Inc. (USA) Warner Chilcott plc (Ireland) Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Avastin in these regions, from 2011 to 2021 (forecast), lik
Published Date: Nov 2016
Published By: QYResearch

Price: $2900
Avastin - Drug Insights, 2016
Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.
Published Date: Jan 2016
Published By: DelveInsight

Price: $1000
Kidney Cancer Drugs Market (Major Drugs: Afinitor (Everolimus), Avastin (Bevacizumab), Inlyta (Axitinib), Nexavar (Sorafenib), Proleukin (Aldesleukin), Sutent (Sunitinib), Torisel (Temsirolimus), Votrient (Pazopanib)) - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Kidneys are among the most crucial organs of the human body. Their role in regulating blood pressure and serving homeostatic functions is critical in maintaining the balance of nutrients and toxins in the body. Kidneys serve as natural blood filters, removing the water-soluble wastes and reabsorbing the essential elements from the blood. Since they play such a crucial role, kidneys require constant regeneration of dead nephrons and proper blood circulation to maintain healthy cell growth, due to which, they are susceptible to metastasis and cancerous tumors. Renal cell carcinoma, the most common type of kidney cancer, is among the toughest cancers to treat, especially in the advanced stages. Until 1980’s, the treatment of kidney cancer included surgical removal of the kidneys. The
Published Date: Jan 2015
Published By: Transparency

Price: $5795
Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023
GlobalData has released its new PharmaPoint Drug Evaluation report, Avastin (Colorectal Cancer) Forecast and Market Analysis to 2023. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus represents a huge burden on healthcare systems. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the colorectal cancer market, with coverage of multiple settings of the disease including neoadjuvant/adjuvant, first-, second-, third-line KRAS wild-type and mutation-positive, and fourth-line metastatic. In terms of targeted treatments, the metastatic CRC treatment landscape is mature, including the branded treatments Avastin (bevaci
Published Date: Nov 2014
Published By: GlobalData

Price: $3495
Avastin (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023
Avastin (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023SummaryMacular Edema is a condition where fluid accumulates on the macula, leading to vision impairment or in severe cases even vision loss. The three main types of ME are diabetic macular edema (DME), and macular edema following either a central or branch retinal vein occlusion (ME-CRVO and ME-BRVO). Age-related macular degeneration (AMD) is a painless eye condition which leads to gradual, irreversible, loss of central vision, and is one of the leading causes of blindness among people aged 50 and over in the developed world. Currently the ME and AMD markets are dominated by the use of anti-VEGF monotherapy, however, in recent years, corticosteroid implants have been reaching the ME market which could ch
Published Date: Oct 2014
Published By: GlobalData

Price: $3495
Avastin-Drug Insights,2014
The Report will be Dispatched in 3 working days.  DelveInsights pharmaceuticals report, Avastin - Drug Insights, 2014 provides Avastin marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report is built using data and information sourced from DelveInsight proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party source
Published Date: Aug 2014
Published By: DelveInsight

Price: $1000
Avastin (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022
The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic retinopathy segment of the market has recently seen rapid uptake of novel anti-VEGF therapies and is experiencing a strong growth. On the other hand, the diabetic neuropathy and nephropathy segments face the barrier in and increasing number of generic competitors. Avastin (bevacizumab) is a recombinant humanized IgG1 mAb that specifically binds to VEGF-A, thereby preventing the interaction of VEGF-A with its receptors on the surface of endothelial cells. T
Published Date: Dec 2013
Published By: GlobalData

Price: $3495
Avastin (Non-Small Cell Lung Cancer) - Forecast and Market Analysis to 2022
Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of targeted therapies for patients with specific biomarkers has begun to fragment the NSCLC treatment landscape into smaller niche patient populations. Over the forecast period, this trend will continue with the launch of multiple new drugs in several new drug classes to address the high unmet need among NSCLC patients, and provide new treatment options for previously underserved populations. Launch of premium-priced drug candidates combined with increasing incident cases of the disease will be major drivers of growth in the major markets. Avastin is a first-generation antiang
Published Date: Jun 2013
Published By: GlobalData

Price: $3495
Avastin (Renal Cell Carcinoma) Analysis and Forecasts to 2022
Avastin (Renal Cell Carcinoma) Analysis and Forecasts to 2022 GlobalDatas pharmaceuticals report, Avastin (Renal Cell Carcinoma) Analysis and Forecasts to 2022 provides Avastin sales forecasts for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2012-2022). The report also includes information on Renal Cell Carcinoma market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysi
Published Date: Mar 2012
Published By: GlobalData

Price: $2000
Avastin (Breast Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Avastin (Breast Cancer) Analysis and Forecasts to 2020 provides Avastin sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2007-2020). The report also includes information on Breast Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy a
Published Date: Dec 2011
Published By: GlobalData

Price: $2000
Avastin (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Avastin (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020 provides Avastin sales Forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2006-2020). The report also includes information on Non-Small Cellular Lung Cancer. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry experts. Note
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Avastin (Head and Neck Cancer) Analysis and Forecasts to 2020
SummaryGlobalDatas pharmaceuticals report, Avastin (Head and Neck Cancer) Analysis and Forecasts to 2020 provides Avastin sales forecasts for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2015-2020). The report also includes information on Head and Neck Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.Note: This is a on-d
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Avastin (Renal Cell Carcinoma) Analysis and Forecasts to 2020
SummaryGlobalDatas pharmaceuticals report, Avastin (Renal Cell Carcinoma)- Analysis and Forecasts to 2020 provides Avastin sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2008-2020). The report also includes information on Renal Cell Carcinoma market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.Note: This i
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Avastin (bevacizumab) Analysis and Market Forecasts from 2016 to 2020
GlobalDatas pharmaceuticals report, Avastin (bevacizumab) Analysis and Market Forecasts from 2016 to 2020 provides Avastin sales estimates for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2016-2020). The report also includes information on Liver Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope The
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Avastin (Cervical Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Avastin (Cervical Cancer) - Analysis and Forecasts to 2020 provides Avastin sales forecasts for the US. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Cervical Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry experts. Note: This is a on-demand report
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Avastin (Ovarian Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Avastin (Ovarian Cancer) - Analysis and Forecasts to 2020 provides Avastin sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2012-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy
Published Date: Oct 2011
Published By: GlobalData

Price: $2000

Upcoming Reports

Wheelchair Accessible Vehicle Converters Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Vehicles which are converted in a way that have easy access for wheelchairs are termed as wheelchair accessible vehicles or WAV’s. The vehicles are specially converted from a standard vehicle to WAV in order to accommodate the wheelchair. Wheelchair accessible vehicles are considered as mult
Published By: Transparency
Price: $5795
Enteral Nutrition Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Enteral nutrition pumps also known as enteral feeding pumps are used to deliver nutritious foods containing carbohydrate, protein, fat, vitamin, minerals and water by inserting directly into the stomach or parts of small intestine. Enteral nutrition pumps are recommended to patients suffering from
Published By: Transparency
Price: $5795
Residential Water Treatment Equipment Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2014 - 2020
Increasing industrial and environmental pollution around the world is increasing the need for water treatment. Water pollution due to increasing industrialization and environment pollution is leading to death and spread of diseases. It also adversely affects more than 1 billion of population every
Published By: Transparency
Price: $5795
Steam Boiler System Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
The growing need of effective heating systems as well as the requirement of increasing operating efficiency of residential and commercial complexes has led to the widespread adoption of steam boiler systems. This technology provides high steam temperature and improved pressure parameters to achiev
Published By: Transparency
Price: $5795
Seismic Survey Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast 2014 - 2020
Increasing exploration activities owing to the efforts of oil and gas companies to locate new oil and gas reserves is expected to drive the global seismic survey market during the forecast period. Oil and gas companies use seismic surveys to map and interpret potential petroleum reserves.  P
Published By: Transparency
Price: $5795

Back To Top